Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome
Aim: To study therapeutic effects of eprosartan on intravascular platelet activity in patients with arterial hypertension (AH) and metabolic syndrome (MS). Material and methods: In total, 32 participants received eprosartan (600 mg/d) for 4 months. Dynamics of lipid peroxidation in plasma and platel...
Saved in:
Main Authors: | I. N. Medvedev, T. A. Kumova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2008-02-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1525 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of platelet hemostasis effects for angiotensin receptor blockers in patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2007-08-01) -
Intravascular platelet activity correction by fosinopril in arterial hypertension patients with metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2006-10-01) -
Valsartan effects on platelet activity in patients with arterial hypertension and metabolic syndrom
by: I. N. Medvedev, et al.
Published: (2007-06-01) -
Reduced platelet aggregation in losartan-treated patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2008-10-01) -
Nebivolol therapy and reduction of intravascular platelet activity in patients with atrial hypertension and metabolic syndrome
by: I. N. Medvedev
Published: (2006-06-01)